Carlsbad, CA (July 11, 2023) – RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection recognizes RCE.ai’s groundbreaking advancements in healthcare technology and its potential to transform patient care.
The Cedars-Sinai Accelerator, located in Los Angeles, California, is renowned for supporting early-stage companies developing cutting-edge solutions in healthcare.
RCE.ai has gained recognition for its novel optical based technology and artificial intelligence (AI) platform, which is intended to empower healthcare providers in delivering patient care through real-time assessment and clinical decision support. By leveraging machine learning algorithms and deep data analysis, RCE.ai enables clinicians to make more informed decisions, optimize workflows, and potentially improve patient outcomes.
“We are thrilled to be selected for the Cedars-Sinai Accelerator program,” said Atandra Burman, Founder and CEO of RCE.ai. “This opportunity will allow us to collaborate with industry leaders, access valuable resources, and refine our solution to better address the evolving needs of patients and healthcare providers.”
The inclusion of RCE.ai in the accelerator program highlights the company’s potential to revolutionize healthcare delivery and patient management. By integrating RCE’s technology into clinical workflows, hospitals and healthcare systems can enhance efficiency, reduce costs, and ultimately improve patient satisfaction.
Through the Cedars-Sinai Accelerator program, RCE.ai will have access to a range of resources, including mentorship from leading industry experts, guidance in business development and strategy, as well as connections to Cedars-Sinai’s vast network of healthcare professionals.
About Cedars-Sinai Accelerator:
The Cedars-Sinai Accelerator program transforms healthcare quality, efficiency, and care delivery by helping entrepreneurs bring their innovative technology products to market. This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than three hundred leading clinicians and executives, access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2016, the accelerator has helped dozens of companies transform healthcare delivery and patient care.
About RCE.ai:
RCE.ai, an innovative artificial intelligence (AI) based medical technology company launched in Carlsbad, Calif., in 2018, is dedicated to early heart attack detection. The company has revolutionized the monitoring of cardiac injury by introducing Infrasensor™, a non-invasive infrared-based wearable device. RCE’s proprietary transdermal approach, enhanced with deep learning techniques, analyzes and associates unique optical signatures with cardiac conditions in real-time. This AI-coupled transdermal approach enables the potential application of RCE’s technology in various emergency care settings and remote monitoring applications. Presently, RCE is engaged in clinical studies to optimize the Infrasensor for clinical use. Through ongoing clinical studies, the company hopes to soon secure FDA approval for its technology, opening the door to making it available for sale in the United States.